Arxis (ARXS) director Form 3 shows no reported holdings

Rhea-AI Filing Summary

Arxis, Inc. director Stephen Duane Oetgen filed a Form 3, which is an initial statement of beneficial ownership for insiders. The data shows no reported transactions, zero shares bought or sold, and a neutral net buy/sell direction, with no derivative securities listed.

Key Terms

Form 3, reporting person, derivative securities

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3): {"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons": [ { "name": "Oetgen Stephen Duane""

derivative securities financial

""derivativeSummary": []"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Oetgen Stephen Duane

(Last) (First) (Middle)

1332 BLUE HILLS AVENUE

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/15/2026

3. Issuer Name and Ticker or Trading Symbol
Arxis, Inc. [ ARXS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Jennifer Allen, attorney-in-fact for Stephen Oetgen	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Arxis (ARXS) Form 3 filing show for Stephen Duane Oetgen?

The Form 3 identifies Stephen Duane Oetgen as a director of Arxis, Inc. and reporting person. It lists no transactions, no derivative positions, and zero net shares bought or sold, indicating only an initial ownership report with no position data provided.

Are there any share purchases or sales reported in this Arxis (ARXS) Form 3?

No share purchases or sales are reported. The transaction summary shows zero buy and sell counts, zero net buy/sell shares, and a neutral net buy/sell direction, meaning no insider trading activity is disclosed in this particular Form 3 dataset.

Does the Arxis (ARXS) Form 3 include any derivative securities for the director?

The Form 3 data shows no derivative securities. The derivative summary is empty and derivativeTransactionCount is zero, indicating the reporting person has no listed options, warrants, or other derivative positions in this filing snapshot for Arxis, Inc.

What is the insider role reported for Stephen Duane Oetgen at Arxis (ARXS)?

Stephen Duane Oetgen is reported as a director of Arxis, Inc. in this Form 3. The fields confirm director status with no officer role or ten percent owner designation, clarifying his relationship to the company as board-level oversight rather than executive management.

Does this Arxis (ARXS) Form 3 show any existing share holdings for the director?

The dataset indicates no reported holdings. HoldingEntries is zero, transactions are empty, and there are no derivative positions listed, so the filing as provided does not show any specific common stock or derivative share count for the director at Arxis, Inc.